Anguilla Business Daily
SEE OTHER BRANDS

Informing on business and economy news in Anguilla

Anguilla Business Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Anguilla Business Daily.

Press releases published on August 4, 2025

Vimeo Q2 2025 Shareholder Letter Available on Company's IR Site

Vimeo Q2 2025 Shareholder Letter Available on Company's IR Site

NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Vimeo posted its second quarter 2025 shareholder letter on the investor relations section of its website at https://www.vimeo.com/investors. Vimeo will live stream a video conference to answer questions regarding …

Sable Offshore Corp. (SOC) Hit with Lawsuit Over Alleged Misleading Statements on California Oil Restart – Hagens Berman

Sable Offshore Corp. (SOC) Hit with Lawsuit Over Alleged Misleading Statements on California Oil Restart – Hagens Berman

SAN FRANCISCO, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Sable Offshore Corp. (NYSE: SOC) is now at the center of a securities class-action lawsuit, alleging that the company misled investors to inflate its stock price just before a major secondary offering. The …

Crane NXT to Participate in the Oppenheimer 28th Annual Technology, Internet & Communications Conference

Crane NXT to Participate in the Oppenheimer 28th Annual Technology, Internet & Communications Conference

WALTHAM, Mass., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Crane NXT, Co. (NYSE: CXT), a premier industrial technology company, announced that Aaron Saak, President and Chief Executive Officer, and Christina Cristiano, Senior Vice President and Chief Financial …

PennantPark Floating Rate Capital Ltd. Announces Monthly Distribution of $0.1025 per Share

PennantPark Floating Rate Capital Ltd. Announces Monthly Distribution of $0.1025 per Share

MIAMI, Aug. 04, 2025 (GLOBE NEWSWIRE) -- PennantPark Floating Rate Capital Ltd. (the "Company") (NYSE: PFLT) declares its monthly distribution for August 2025 of $0.1025 per share, payable on September 2, 2025 to stockholders of record as of August 15, …

CVRx Reports Second Quarter 2025 Financial and Operating Results

CVRx Reports Second Quarter 2025 Financial and Operating Results

MINNEAPOLIS, Aug. 04, 2025 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular …

Inspirato to Announce Second Quarter 2025 Financial Results on Tuesday, August 12, 2025

Inspirato to Announce Second Quarter 2025 Financial Results on Tuesday, August 12, 2025

DENVER, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Inspirato Incorporated (“Inspirato” or the “Company”) (Nasdaq: ISPO), the premier luxury vacation club and property technology company, today announced plans to release financial and operating results for the …

Castle Biosciences Reports Second Quarter 2025 Results

Castle Biosciences Reports Second Quarter 2025 Results

Delivered Q2 2025 revenue of $86 million Q2 2025 total test reports for our core revenue drivers (DecisionDx®-Melanoma, TissueCypher®) increased 33% over Q2 2024 Raising full-year 2025 revenue guidance range to $310-320 million from $287-297 million …

TTM Technologies, Inc. Announces Upcoming Conference Participation

TTM Technologies, Inc. Announces Upcoming Conference Participation

SANTA ANA, Calif., Aug. 04, 2025 (GLOBE NEWSWIRE) -- TTM Technologies, Inc. (NASDAQ: TTMI), today announced that members of its management team will attend the following investor conferences: Needham Virtual Industrial Technology, Robotics and Clean Tech …

Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)

Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)

FOSTER CITY, Calif., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases …

Tactile Systems Technology, Inc. Reports Second Quarter 2025 Financial Results

Tactile Systems Technology, Inc. Reports Second Quarter 2025 Financial Results

MINNEAPOLIS, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today reported financial results for the …

OrthoPediatrics Corp. to Participate in the 45th Canaccord Genuity Annual Growth Conference

OrthoPediatrics Corp. to Participate in the 45th Canaccord Genuity Annual Growth Conference

WARSAW, Ind., Aug. 04, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that Dave Bailey, President …

MercadoLibre Inc., Reports Second Quarter 2025 Financial Results

MercadoLibre Inc., Reports Second Quarter 2025 Financial Results

Montevideo, Aug. 04, 2025 (GLOBE NEWSWIRE) -- MercadoLibre, Inc. (Nasdaq: MELI) (http://www.mercadolibre.com) today reported financial results for the second quarter ended June 30, 2025, in a Letter to Shareholders, which is now posted to the company’s …

Denny’s Corporation Reports Results for Second Quarter 2025

Denny’s Corporation Reports Results for Second Quarter 2025

SPARTANBURG, S.C., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Denny’s Corporation (the "Company") (NASDAQ: DENN), owner and operator of Denny's Inc. ("Denny's") and Keke's Inc. ("Keke's") today reported results for its second quarter ended June 25, 2025 and …

Mineralys Therapeutics to Announce Second Quarter 2025 Financial Results and Host Conference Call on Tuesday, August 12, 2025

Mineralys Therapeutics to Announce Second Quarter 2025 Financial Results and Host Conference Call on Tuesday, August 12, 2025

RADNOR, Pa., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (NASDAQ: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as hypertensive nephropathy, …

Armada Hoffler Reports Second Quarter 2025 Results

Armada Hoffler Reports Second Quarter 2025 Results

GAAP Net Income of $0.04 Per Diluted Share for the Second Quarter Normalized FFO of $0.25 Per Diluted Share for the Second Quarter Same Store NOI Growth of 1.4% (GAAP) Positive Office Releasing Spreads of 11.7% (GAAP) and 5.5% (Cash) Positive Retail …

Inseego Continues the Strategic Transformation of Its Business With Two Key Hires

Inseego Continues the Strategic Transformation of Its Business With Two Key Hires

SAN DIEGO, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Inseego Corp. (Nasdaq: INSG), a global leader in wireless broadband, including 5G mobile broadband and 5G fixed wireless access (FWA) solutions, today announced two new additions to its executive leadership team …

iMDx to Release Second Quarter 2025 Results on August 11, 2025 and Attend Needham Virtual MedTech and Diagnostics Conference

iMDx to Release Second Quarter 2025 Results on August 11, 2025 and Attend Needham Virtual MedTech and Diagnostics Conference

NASHVILLE, Tenn., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics, or iMDx, (Nasdaq: IMDX), today announced that it will report second quarter 2025 financial results after the market closes on Monday, August 11, 2025. iMDx will host a live …

HEO and Satellogic Expand Agreement with Exclusive Access to Non-Earth Imagery for Space Domain Awareness

HEO and Satellogic Expand Agreement with Exclusive Access to Non-Earth Imagery for Space Domain Awareness

NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Satellogic, Inc. (NASDAQ: SATL), a leader in satellite manufacturing and high-resolution Earth observation data, today announced an expanded agreement with HEO, the world’s leading commercial provider of non- …

89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN FRANCISCO, Aug. 04, 2025 (GLOBE NEWSWIRE) -- 89bio, Inc. (the “Company” or “89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and …

Nasdaq Reports July 2025 Volumes

Nasdaq Reports July 2025 Volumes

NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today reported monthly volumes for July 2025 on its Investor Relations website. A data sheet showing this information can be found at: http://ir.nasdaq.com/financials/volume-statistics. …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions